Advanced search
Publication Cover
Nordic Journal of Psychiatry Volume 65, 2011 - Issue 6
Submit an article Journal homepage
305
Views
15
CrossRef citations to date
0
Altmetric
Research Article

A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden

Eva LindströmDepartment of Psychiatry, University Hospital, Uppsala, Sweden
,
Jonas EberhardDepartment of Psychosis Studies, Institute of Psychiatry, King's College, London, UK
,
Björn M. ForsDepartment of Psychiatry, University Hospital, Uppsala, Sweden
,
Karina HansenH. Lundbeck A/S, Health Economics & HTA Management, Paris, FranceCorrespondence[email protected]
&
Christophe SapinH. Lundbeck A/S, Global Outcomes Research, Paris, France
Pages 403-413 | Accepted 17 May 2011, Published online: 19 Jul 2011

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Benjamin Kearns, Katy Cooper, Anna Cantrell & Chloe Thomas. (2021) Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain. Neuropsychiatric Disease and Treatment 17, pages 125-137.
Read now
Junwen Zhou, Aurélie Millier & Mondher Toumi. (2018) Systematic review of pharmacoeconomic models for schizophrenia. Journal of Market Access & Health Policy 6:1.
Read now
Thomas R. Einarson, Hanna Pudas, Pushpendra Goswami, Kristel van Impe & Basil G. Bereza. (2016) Pharmacoeconomics of long-acting atypical antipsychotics for acutely relapsed chronic schizophrenia in Finland. Journal of Medical Economics 19:2, pages 121-130.
Read now
Maria Rosaria Anna Muscatello, Antonio Bruno, Paolo Micali Bellinghieri, Gianluca Pandolfo & Rocco Antonio Zoccali. (2014) Sertindole in schizophrenia: efficacy and safety issues. Expert Opinion on Pharmacotherapy 15:13, pages 1943-1953.
Read now
Thomas R. Einarson, Colin Vicente, Roman Zilbershtein, Charles Piwko, Christel N. Bø, Hanna Pudas, Rasmus Jensen & Michiel E.H. Hemels. (2014) Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden. Nordic Journal of Psychiatry 68:6, pages 416-427.
Read now
Birgitta von Schéele, Josephine Mauskopf, Thor-Henrik Brodtkorb, Claire Ainsworth, Carmen Galani Berardo & Anita Patel. (2014) Relationship between modeling technique and reported outcomes: case studies in models for the treatment of schizophrenia. Expert Review of Pharmacoeconomics & Outcomes Research 14:2, pages 235-257.
Read now
Enrico Cocchi, Antonio Drago, Diana de Ronchi & Alessandro Serretti. (2014) The genetics of vascular incidents associated with second-generation antipsychotic administration. Expert Review of Clinical Pharmacology 7:1, pages 75-90.
Read now
Thomas R. Einarson & Michiel E. H. Hemels. (2013) Validation of an economic model of paliperidone palmitate for chronic schizophrenia. Journal of Medical Economics 16:11, pages 1267-1274.
Read now
Natalie C. Edwards, Erik Muser, Dilesh Doshi & John Fastenau. (2012) The threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost saving. Journal of Medical Economics 15:4, pages 623-634.
Read now

Articles from other publishers (6)

Huajie Jin, Stewart Robinson, Wenru Shang, Evanthia Achilla, David Aceituno & Sarah Byford. (2021) Overview and Use of Tools for Selecting Modelling Techniques in Health Economic Studies. PharmacoEconomics 39:7, pages 757-770.
Crossref
Huajie Jin, Paul Tappenden, Stewart Robinson, Evanthia Achilla, James H. MacCabe, David Aceituno & Sarah Byford. (2020) A Systematic Review of Economic Models Across the Entire Schizophrenia Pathway. PharmacoEconomics 38:6, pages 537-555.
Crossref
Iara Carolina Barbosa Henrique, Tácio Lima, Daniela Oliveira Melo & Patricia Melo Aguiar. (2019) Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review. Journal of Clinical Pharmacy and Therapeutics 45:1, pages 1-15.
Crossref
Mark Pennington & Paul McCrone. (2017) The Cost of Relapse in Schizophrenia. PharmacoEconomics 35:9, pages 921-936.
Crossref
Gregory Kruse, Bruce J. O. Wong, Mei Sheng Duh, Patrick Lefebvre, Marie-Hélène Lafeuille & John M. Fastenau. (2015) Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment. PharmacoEconomics 33:10, pages 1049-1067.
Crossref
Michael Sonntag, Hans-Helmut König & Alexander Konnopka. (2013) The Estimation of Utility Weights in Cost-Utility Analysis for Mental Disorders: A Systematic Review. PharmacoEconomics 31:12, pages 1131-1154.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.